e-learning
resources
Paris 2018
Monday, 17.09.2018
Mesothelioma and pleural malignancy: investigations and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of 2-Deoxy-glucose with Cisplatin-Pemetrexed in mesothelioma sphere formation.
R. Jagirdar (Larissa, Greece), I. Georgianni (Larissa, Greece), E. Pitaraki (Larissa, Greece), E. Papazoglou (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece)
Source:
International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Session:
Mesothelioma and pleural malignancy: investigations and management
Session type:
Thematic Poster
Number:
2866
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Jagirdar (Larissa, Greece), I. Georgianni (Larissa, Greece), E. Pitaraki (Larissa, Greece), E. Papazoglou (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece). Effects of 2-Deoxy-glucose with Cisplatin-Pemetrexed in mesothelioma sphere formation.. 2866
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Diagnosis and staging of malignant pleural mesothelioma
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Mesothelioma
Related content which might interest you:
Primary cilium modulates mesothelioma cell viability and 3D sphere formation.
Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease
Year: 2021
Effects of mTOR Inhibition in malignant mesothelioma
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
Hypertonicity increases apparent water permeability in benign mesothelial cells but differentially regulates it in epithelioid mesothelioma cells depending on the osmotic agent
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Effect of asbestos on gene expression of tight junctions components in malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
mTOR inhibition blocks tumor growth and pleural fluid accumulation in experimental murine mesothelioma
Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma
Year: 2011
Effects of 2-Deoxy-glucose (2DG) with cisplatin and pemetrexed in mesothelioma cell mediated collagen gel contraction.
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019
Effects of Cisplatin and Pemetrexed on the cell viability and cell adhesion of benign mesothelial and mesothelioma cells.
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
MTH-1 inhibition retards mesothelioma progression
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017
The role of Epithelial sodium channel (ENaC) in cell proliferation and tunneling nanotube (TnT) formation in benign mesothelial cells and malignant pleural mesothelioma (MPM) cells.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
Effects of cisplatin and pemetrexed on 3D phenotypes of benign mesothelial and malignant pleural mesothelioma cells
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018
Expression of ERK2 and p38α kinases in pleural mesothelial cells after exposure to asbestos fibers
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice
Source: Eur Respir J 2009; 34: 1159-1167
Year: 2009
Variation of capability of human and sheep pleural mesothelial cells to transport Na
+
and H
2
O. Involvement of lymphatic drainage?
Source: Eur Respir J 2005; 26: Suppl. 49, 552s
Year: 2005
Novel Synthetic lignan reduces asbestos-induced damage in human pleural mesothelial cells-Potential clinical usefulness in inhibiting pleural malignant mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Experimental target therapy in mesothelioma cells
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Impact of angiopoietin-1 in mesothelioma progression
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Primary cilium regulates cell migration and mechanical contraction in mesothelioma cell models.
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021
Over-expression of chloride intracellular channels (CLICs) 3 and 4 in malignant pleural mesothelioma
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept